ESC 365 - Optimal strategy for antiplatelet therapy after coronary drug-eluting stent implantation in high-risk "TWILIGHT-like" patients with diabetes mellitus

EAPC Premium Access

Optimal strategy for antiplatelet therapy after coronary drug-eluting stent implantation in high-risk "TWILIGHT-like" patients with diabetes mellitus

Session: Young Investigators Award Secondary Prevention and Rehabilitation

Topic: Pharmacotherapy

Speaker: Doctor H. Wang (Beijing, CN)

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Doctor Haoyu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

5 more presentations in this session

Physical activity and sedentary behaviour in cardiovascular disease patients during the COVID-19 lockdown in the Netherlands; a longitudinal cohort study

Speaker: Mr B. van Bakel (Nijmegen, NL)

Lifestyle management and compliance in coronary patients: The gender gap. Results from the ESC EORP EUROASPIRE V survey

Speaker: Mr P. Vynckier (Ghent, BE)

Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study

Speaker: Doctor B. Buckley (Liverpool, GB)

Effectiveness of cardiac telerehabilitation with relapse prevention compared to centre-based cardiac rehabilitation: results from the SmartCare-CAD randomised controlled trial

Speaker: Mr R. Brouwers (Eindhoven, NL)

Low skeletal muscle density combined with muscle dysfunction predicts adverse events after adult cardiovascular surgery

Speaker: Mr M. Yamashita (Sagamihara, JP)

Access the full session

Young Investigators Award Secondary Prevention and Rehabilitation

Speakers: Doctor H. Wang, Mr B. van Bakel, Mr P. Vynckier, Doctor B. Buckley, Mr R. Brouwers...

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources